Item 2.02
Results of Operations and Financial Condition.
As previously disclosed,
21st Century Oncology Holdings, Inc. (the Company) is in the process of finalizing its Form 10-K for the fiscal year ended December 31, 2015. The completion of the process has been delayed as a result of the restatement of prior year financial results. In the interim, the Company is providing the following additional preliminary results. The preliminary results are based on managements current expectations. Actual results could differ materially from such estimates. Final adjustments and other material developments may arise between the date hereof and the date that the Company announces its 2015 year-end and first quarter 2016 results.
Fourth Quarter 2015 Preliminary Results
For the fourth quarter of 2015, the Company expects to report total revenue between $262 million and $279 million and Pro Forma Adjusted EBITDA between $35 million and $39 million. Cash capital expenditures for the same period are expected to be approximately $6 million.
First Quarter 2016 Preliminary Results
For the first quarter of 2016, the Company expects to report total revenue between $264 million and $281 million and Pro Forma Adjusted EBITDA between $38 million and $42 million. Cash capital expenditures for the same period are expected to be approximately $12 million. The Company expects to report cash and cash equivalents as of March 31, 2016 of $73 million.
The information in this item shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended (the Securities Act), or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
Forward-Looking Statements
This Current Report on Form 8-K contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. Statements that include the words believes, expects, anticipates, intends, projects, estimates, plans, may increase, forecast and similar expressions or future or conditional verbs such as will, should, would, may and could are generally forward-looking in nature and not historical facts. Forward-looking statements are based on managements current expectations or beliefs about the Companys future plans, expectations and objectives, including, but not limited to, estimated financial results. These forward-looking statements are not historical facts and are subject to risks and uncertainties that could cause the actual results to differ materially from those projected in these forward-looking statements. Readers of this Current Report on Form 8-K are cautioned not to place undue reliance on forward-looking statements contained herein, which speak only as of the date of this Current Report on Form 8-K. Please refer to the risk factors contained in the Companys other filings with the SEC. The Company undertakes no obligation to publicly update or revise the forward-looking statements contained herein to reflect changed events or circumstances after the date of this Current Report on Form 8-K.
2